ALGS Earnings

Quarterly EPS
$-3.07
Q3 2024
$-13.08
Q4 2024
$5.12
Q1 2025
$-1.53
Q2 2025
$-3.04
Q3 2025
$-1.91
Q4 2025
$-2.21
Q1 2026
$-0.14
Q2 2026
Latest Revenue27.8M
Latest Net Income-1504000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.1427.8M-1504000+2,778.5%+90.8%
Q1 2026-$2.212.8M-23040000+810.0%-143.2%
Q4 2025-$1.91169.0K-19881000-73.1%+85.4%
Q3 2025-$3.04741.0K-31537000-41.6%+1.0%
Q2 2025-$1.53965.0K-15863000-9.0%-288.9%
Q1 2025$5.12311.0K43.1M-68.5%+191.8%
Q4 2024-$13.08629.0K-82150000-76.5%-217.5%
Q3 2024-$3.071.3M-19259000-60.8%+70.4%
Q2 2024$0.811.1M5.1M
Q1 2024-$5.58986.0K-34863000
Q4 2023-$4.122.7M-27892000
Q3 2023-$10.373.2M-18041000
Aligos Therapeutics (ALGS) — Earnings